Cargando…

Influence of continuous renal replacement therapy on the plasma concentration of tigecycline in patients with septic shock: A prospective observational study

Objective: The influence of continuous renal replacement therapy (CRRT) on the steady-state plasma concentration of high-dose tigecycline was investigated in septic shock patients to provide references for drug dosing. Methods: In this prospective observational study, 17 septic shock patients presen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Fang, Cao, Wen-Xiang, Yan, Yu-Ying, Mao, Tian-Tian, Wang, Xian-Wen, Huang, Dan, Qiu, Yu-Shuang, Lu, Wen-Jie, Li, Dong-Jie, Zhuang, Yu-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034132/ https://www.ncbi.nlm.nih.gov/pubmed/36969878 http://dx.doi.org/10.3389/fphar.2023.1118788

Ejemplares similares

Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock
por: Borsuk-De Moor, Agnieszka, et al.
Publicado: (2018)

Population pharmacokinetics of tigecycline in critically ill patients
por: Luo, Xiangru, et al.
Publicado: (2023)

Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients
por: Sun, Li-Hua, et al.
Publicado: (2022)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
por: Zhang, Lei, et al.
Publicado: (2023)

Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis
por: Huang, Po, et al.
Publicado: (2019)

Are Corticosteroids Beneficial for Sepsis and Septic Shock? Based on Pooling Analysis of 16 Studies
por: Yao, Yang-Yang, et al.
Publicado: (2019)

Continuous hemodiafiltration with bicarbonate- and lactate-buffered replacement fluids in septic shock
por: Lewejohann, J-C, et al.
Publicado: (1999)

Population Pharmacokinetics of Tigecycline: A Systematic Review
por: Zhou, Can-Can, et al.
Publicado: (2022)

Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection
por: Yu, Meiling, et al.
Publicado: (2023)

Interactive Effects of Glucocorticoids and Cytochrome P450 Polymorphisms on the Plasma Trough Concentrations of Voriconazole
por: Jia, Su-jie, et al.
Publicado: (2021)

Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report
por: Peng, Danyang, et al.
Publicado: (2022)

The Efficacy and Safety of Esmolol for Septic Shock: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Huang, Po, et al.
Publicado: (2021)

Adjunctive granisetron therapy in patients with sepsis or septic shock (GRANTISS): A single-center, single-blinded, randomized, controlled clinical trial
por: Guan, Jianbin, et al.
Publicado: (2022)

Effects of combination therapy with Shenfu Injection in critically ill patients with septic shock receiving mechanical ventilation: A multicentric, real-world study
por: Li, Xiaoqian, et al.
Publicado: (2022)

Continuous renal replacement therapy with oXiris(®) in patients with hematologically malignant septic shock: A retrospective study
por: Wang, Juan, et al.
Publicado: (2023)

Renal Replacement Techniques in Septic Shock
por: Hellman, Tapio, et al.
Publicado: (2021)

Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects
por: Gotfried, Mark H., et al.
Publicado: (2017)

Changes in Plasma Kynurenic Acid Concentration in Septic Shock Patients Undergoing Continuous Veno-Venous Haemofiltration
por: Dabrowski, Wojciech, et al.
Publicado: (2013)

The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties
por: Xu, Zhijie, et al.
Publicado: (2016)

Clinical outcomes of severe sepsis and septic shock patients with left ventricular dysfunction undergoing continuous renal replacement therapy
por: Yu, Guangwei, et al.
Publicado: (2022)

Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China
por: Leng, Bing, et al.
Publicado: (2022)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Comparative Efficacy of Chinese Herbal Injections for Septic Shock: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Huang, Peiying, et al.
Publicado: (2022)

Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae
por: Tian, Yuan, et al.
Publicado: (2021)

Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury
por: Shum, HP, et al.
Publicado: (2012)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

ALDH2 attenuates myocardial pyroptosis through breaking down Mitochondrion-NLRP3 inflammasome pathway in septic shock
por: Zhang, Ying, et al.
Publicado: (2023)

Evaluation of Continuous Renal Replacement Therapy and Therapeutic Plasma Exchange, in Severe Sepsis or Septic Shock in Critically Ill Children
por: Aygün, Fatih, et al.
Publicado: (2019)

Therapeutic Drug Monitoring of Ceftazidime-Avibactam Concentrations in Carbapenem-Resistant K. pneumoniae-Infected Patients With Different Kidney Statuses
por: Teng, Xin-Qi, et al.
Publicado: (2022)

Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
por: Broeker, A., et al.
Publicado: (2018)

1456. Resistance Mechanisms of Tigecycline in Enterococcus faecalis
por: Bai, Bing, et al.
Publicado: (2020)

Timing of the initiation of continuous renal replacement therapy and clinical outcome in patients with severe sepsis and septic shock
por: Cho, S
Publicado: (2012)

Optimal timing of initiating continuous renal replacement therapy in septic shock patients with acute kidney injury
por: Yoon, Bo Ra, et al.
Publicado: (2019)

Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo
por: Wei, Ziying, et al.
Publicado: (2021)

Efficacy and Safety of Neostigmine Adjunctive Therapy in Patients With Sepsis or Septic Shock: A Randomized Controlled Trial
por: El-Tamalawy, Mona M., et al.
Publicado: (2022)

Blockage of S100A8/A9 ameliorates septic nephropathy in mice
por: Shi, Wei, et al.
Publicado: (2023)

Case Report: Therapeutic Drug Monitoring of Polymyxin B During Continuous Renal Replacement Therapy in Two Pediatric Patients: Do Not Underestimate Extracorporeal Clearance
por: Xu, Caifang, et al.
Publicado: (2022)

Surgical Management for Chronic Destructive Septic Hip Arthritis: Debridement, Antibiotics, and Single‐Stage Replacement is as Effective as Two‐Stage Arthroplasty
por: Zhang, Chao‐fan, et al.
Publicado: (2022)

Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM
por: Shi, Xiaoping, et al.
Publicado: (2021)

High Mortality in Severe Sepsis and Septic Shock Patients with Do-Not-Resuscitate Orders in East Asia
por: Huang, Chun-Ta, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6lp03jk62jo77q0b4ke5tp7jsu